...
首页> 外文期刊>Journal of Molecular Biology >The catalytic subunit of Shiga-like toxin 1 interacts with ribosomal stalk proteins and is inhibited by their conserved C-terminal domain
【24h】

The catalytic subunit of Shiga-like toxin 1 interacts with ribosomal stalk proteins and is inhibited by their conserved C-terminal domain

机译:志贺样毒素1的催化亚基与核糖体茎蛋白相互作用,并受其保守的C端结构域抑制

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Shiga-like toxin 1 (SLT-1) is a type II ribosome-inactivating protein; its A(1) domain blocks protein synthesis in eukaryotic cells by catalyzing the depurination of a single adenine base in 28 S rRNA. The molecular mechanism leading to this site-specific depurination event is thought to involve interactions with eukaryotic ribosomal proteins. Here, we present evidence that the A(1) chain of SLT-1 binds to the ribosomal proteins P0, P1, and P2. These proteins were identified from a HeLa cell lysate by tandem mass spectrometry, and subsequently confirmed to bind to SLT-1 A(1) chain by yeast-two-hybrid and pull-down experiments using candidate full-length proteins. Moreover, the removal of the last 17 amino acids of either protein P1 or P2 abolishes the interaction with the A(1) chain, whereas P0, lacking this common C terminus, still binds to the A(1) domain. In vitro pulldown experiments using fusion protein-tagged C-terminal peptides corresponding to the common 7, 11, and 17 terminal residues of P1 and P2 confirmed that the A(1) chain of SLT-1 as well as the A chain of ricin bind to this shared C-terminal peptide motif. More importantly, a synthetic peptide corresponding to the 17 amino acid C terminus of P1 and P2 was shown to inhibit the ribosome-inactivating function of the A(1) chain of SLT-1 in an in vitro transcription and translation-coupled assay. These results suggest a role for the ribosomal stalk in aiding the A(1) chain of SLT-1 and other type II ribosome-inactivating proteins in localizing its catalytic domain near the site of depurination in the 28 S rRNA. (c) 2008 Elsevier Ltd. All rights reserved.
机译:志贺样毒素1(SLT-1)是II型核糖体失活蛋白。它的A(1)域通过催化28 S rRNA中单个腺嘌呤碱基的脱嘌呤来阻止真核细胞中的蛋白质合成。据认为导致该位点特异性脱嘌呤事件的分子机制涉及与真核核糖体蛋白的相互作用。在这里,我们提供证据表明SLT-1的A(1)链与核糖体蛋白P0,P1和P2结合。这些蛋白质是通过串联质谱从HeLa细胞裂解物中鉴定出来的,随后通过使用候选全长蛋白质的酵母双杂交和下拉实验证实与SLT-1 A(1)链结合。此外,蛋白质P1或P2的最后17个氨基酸的去除消除了与A(1)链的相互作用,而缺少此公共C末端的P0仍与A(1)域结合。使用与P1和P2的共同7、11和17末端残基相对应的融合蛋白标签C末端肽进行体外下拉实验,证实SLT-1的A(1)链和蓖麻毒蛋白的A链结合这个共享的C端肽基序。更重要的是,在体外转录和翻译偶联测定中,与P1和P2的17个氨基酸C末端相对应的合成肽显示出抑制SLT-1 A(1)链核糖体失活的功能。这些结果表明核糖体茎在协助SLT-1和其他II型核糖体失活蛋白的A(1)链中将其催化结构域定位在28 S rRNA中的纯化区域附近的作用。 (c)2008 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号